DAY ONE BIOPHARMACEUTICALS I (DAWN) Stock Analyst Ratings
NASDAQ:DAWN - Nasdaq - US23954D1090 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to DAWN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 36.15. This target is 190.86% above the current price.
DAWN was analyzed by 16 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about DAWN.
In the previous month the buy percentage consensus was at a similar level.
DAWN was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-10 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-01-13 | Needham | Reiterate | Buy -> Buy |
| 2025-01-07 | B of A Securities | Maintains | Buy -> Buy |
| 2024-12-17 | Jones Trading | Maintains | Buy -> Buy |
| 2024-10-31 | Needham | Reiterate | Buy -> Buy |
| 2024-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-09 | Needham | Maintains | Buy -> Buy |
| 2024-08-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-08-01 | B of A Securities | Upgrade | Underperform -> Buy |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-31 | Needham | Maintains | Buy -> Buy |
| 2024-07-30 | Needham | Reiterate | Buy -> Buy |
| 2024-07-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-06-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-19 | Needham | Reiterate | Buy -> Buy |
| 2024-05-07 | Needham | Reiterate | Buy -> Buy |
| 2024-05-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-25 | Needham | Reiterate | Buy -> Buy |
| 2024-04-24 | Needham | Maintains | Buy -> Buy |
| 2024-04-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-26 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-27 | Oppenheimer | Reiterate | Perform -> Perform |
| 2024-02-27 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-11-07 | Needham | Reiterate | Buy -> Buy |
| 2023-11-07 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-09-12 | Needham | Reiterate | Buy -> Buy |
| 2023-09-12 | Wedbush | Reiterate | Outperform -> Outperform |